key: cord-0915392-80l40kir
authors: Deng, Junwen; Ngo, Tracy; Zhu, Tian Hao; Halverstam, Caroline
title: Telogen Effluvium, Beau’s Lines, and Acral Peeling Associated with COVID-19 Infection
date: 2021-06-06
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.05.026
sha: 2091365d1d386b2e55c0ccf2d4d9bfe429def568
doc_id: 915392
cord_uid: 80l40kir

nan

The management of our patient involved addressing the underlying cause, which in the 115 case of her COVID-19 illness, was self-limited. As telogen effluvium and Beau's lines may take 116 6-12 months to completely resolve, it is important to inform the patient that these cutaneous 117 changes will eventually improve and baseline appearances will be restored. 5 Since cutaneous 118 manifestations may be the only presenting symptom in 12% of COVID-19 patients, continued 119 research is warranted to completely characterize the spectrum of COVID-19 cutaneous 120 manifestations. 2 121 J o u r n a l P r e -p r o o f 

COVID-19: Insight into the asymptomatic SARS-124

Diagnostic value of cutaneous manifestation of 126

SARS-CoV-2 infection

Cutaneous Manifestations of COVID-19: A 129 Systematic Review

COVID-131 19 and multisystem inflammatory syndrome in children and adolescents

Telogen Effluvium: A Review

Telogen effluvium associated 135 with COVID-19 infection

Peeling Skin Disorders: A Paradigm for Skin Desquamation

Beau's Lines and Leukonychia in a COVID-19

COVID-141 19 and multiorgan failure: A narrative review on potential mechanisms

Current 144

Overview on Hypercoagulability in COVID-19

Impact of liver 147 enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-148 19